Literature DB >> 21507356

Regulation of expression and activity of DNA (cytosine-5) methyltransferases in mammalian cells.

Shannon R Morey Kinney1, Sriharsa Pradhan.   

Abstract

Three active DNA (cytosine-5) methyltransferases (DNMTs) have been identified in mammalian cells, Dnmt1, Dnmt3a, and Dnmt3b. DNMT1 is primarily a maintenance methyltransferase, as it prefers to methylate hemimethylated DNA during DNA replication and in vitro. DNMT3A and DNMT3B are de novo methyltransferases and show similar activity on unmethylated and hemimethylated DNA. DNMT3L, which lacks the catalytic domain, binds to DNMT3A and DNMT3B variants and facilitates their chromatin targeting, presumably for de novo methylation. There are several mechanisms by which mammalian cells regulate DNMT levels, including varied transcriptional activation of the respective genes and posttranslational modifications of the enzymes that can affect catalytic activity, targeting, and enzyme degradation. In addition, binding of miRNAs or RNA-binding proteins can also alter the expression of DNMTs. These regulatory processes can be disrupted in disease or by environmental factors, resulting in altered DNMT expression and aberrant DNA methylation patterns.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507356     DOI: 10.1016/B978-0-12-387685-0.00009-3

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  36 in total

1.  Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.

Authors:  Yuhong Luo; Cen Xie; Chad N Brocker; Jie Fan; Xuan Wu; Lijin Feng; Qiong Wang; Jie Zhao; Dasheng Lu; Mayank Tandon; Maggie Cam; Kristopher W Krausz; Weiwei Liu; Frank J Gonzalez
Journal:  Gastroenterology       Date:  2019-05-30       Impact factor: 22.682

Review 2.  Sensitive periods in epigenetics: bringing us closer to complex behavioral phenotypes.

Authors:  Corina Nagy; Gustavo Turecki
Journal:  Epigenomics       Date:  2012-08       Impact factor: 4.778

3.  Epigenetic Advances in Behavioral and Brain Sciences have Relevance for Public Policy.

Authors:  Tania L Roth
Journal:  Policy Insights Behav Brain Sci       Date:  2017-08-24

4.  A Protein Interaction between β-Catenin and Dnmt1 Regulates Wnt Signaling and DNA Methylation in Colorectal Cancer Cells.

Authors:  Jing Song; Zhanwen Du; Mate Ravasz; Bohan Dong; Zhenghe Wang; Rob M Ewing
Journal:  Mol Cancer Res       Date:  2015-03-09       Impact factor: 5.852

Review 5.  An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function.

Authors:  Swayamsiddha Kar; Moonmoon Deb; Dipta Sengupta; Arunima Shilpi; Sabnam Parbin; Jérôme Torrisani; Sriharsa Pradhan; Samir Patra
Journal:  Epigenetics       Date:  2012-08-16       Impact factor: 4.528

Review 6.  Epigenetic Mistakes in Neurodevelopmental Disorders.

Authors:  Giuseppina Mastrototaro; Mattia Zaghi; Alessandro Sessa
Journal:  J Mol Neurosci       Date:  2017-03-02       Impact factor: 3.444

Review 7.  Cancer genetics and epigenetics: two sides of the same coin?

Authors:  Jueng Soo You; Peter A Jones
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

8.  Status epilepticus triggers early and late alterations in brain-derived neurotrophic factor and NMDA glutamate receptor Grin2b DNA methylation levels in the hippocampus.

Authors:  R Ryley Parrish; A J Albertson; S C Buckingham; J J Hablitz; K L Mascia; W Davis Haselden; F D Lubin
Journal:  Neuroscience       Date:  2013-06-27       Impact factor: 3.590

Review 9.  Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities.

Authors:  Navneet Ammal Kaidery; Shaista Tarannum; Bobby Thomas
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 10.  Epigenetics and addiction.

Authors:  J L Cadet; M T McCoy; S Jayanthi
Journal:  Clin Pharmacol Ther       Date:  2016-02-22       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.